Biology subjects

Sala, I.

Publications and source records attributed to Sala, I..

3 recordsLinked to original sources

bioRxiv2026

Predicting cellular functions of human phosphosites

Protein phosphorylation is a regulatory switch that controls essentially all cellular processes, including metabolism, cell cycle progression, and DNA repair. Furthermore, by modulating specific regions and activities of a protein, phosphorylation sites can independently coordinate the proteins involvement in distinct cellular processes. Despite the importance of this regulatory mechanism, the majority of human phosphosites have not been functionally characterized. Here we have developed biologically informed predictors of phosphosite cellular function by integrating protein functional annotation, recognition by upstream kinases, and regulation across phosphoproteomics perturbations. To enable this we harmonized public phosphoproteomics data into an atlas of nearly 2,000 perturbations and more than 16 million quantifications, providing a powerful resource for studying phosphosite regulation. We applied our predictors to functionally characterise thousands of understudied phosphosites, revealing many phosphosite functions that could not be inferred from protein functional annotation, and functionally divergent phosphosites within the same protein. Using cancer multi-omics data we characterized connections between these phosphosites and other molecular layers. Finally, we illuminated novel signaling axes within the DNA repair pathway, and demonstrated that phosphosites on PPM1G and KHSRP modulate cell survival under DNA damage. Our work represents a powerful resource for dissecting the cellular consequences of protein phosphorylation.

genomics↗

bioRxiv2025

Directed evolution of compact RNA-guided nucleases for homology-directed repair in mammalian cells

RNA-guided nucleases enable DNA editing and offer promise for treating genetic diseases, particularly when used for precise sequence replacement. However, many of the most effective enzymes, such as S. pyogenes Cas9, are too large for delivery using vectors like adeno-associated virus (AAV). This has prompted interest in smaller alternatives from the Cas12f and TnpB families. Yet, these nucleases often show low activity in mammalian cells, limiting their utility. To address this, we used directed evolution in human cells to select variants with greatly improved activity. The resulting variants, Cas12f1Super and TnpBSuper, exhibited up to 11-fold increase in editing efficiency without increased off-target effects. When tested as a base editor, Cas12f1Super showed up to 10-fold improvement relative to the previously engineered CasMINI, suggesting utility beyond nuclease-related activities. These compact and efficient genome editors expand the current toolkit and hold promise for both research and therapeutic use in mammalian systems.

bioengineering↗

bioRxiv2019

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Alzheimers disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. Elucidating the genetic architecture of additional AD-related phenotypic traits, ideally those linked to the underlying disease process, holds great promise in gaining deeper insights into the genetic basis of AD and in developing better clinical prediction models. To this end, we generated genome-wide single-nucleotide polymorphism (SNP) genotyping data in 931 participants of the European Medical Information Framework Alzheimers Disease Multimodal Biomarker Discovery (EMIF-AD MBD) sample to search for novel genetic determinants of AD biomarker variability. Specifically, we performed genome-wide association study (GWAS) analyses on 16 traits, including 14 measures of amyloid-beta (A{beta}) and tau-protein species in the cerebrospinal fluid (CSF). In addition to confirming the well-established effects of apolipoprotein E (APOE) on diagnostic outcome and phenotypes related to A{beta}42, we detected novel potential signals in the zinc finger homeobox 3 (ZFHX3) for CSF-A{beta}38 and CSF-A{beta}40 levels, and confirmed the previously described sex-specific association between SNPs in geminin coiled-coil domain containing (GMNC) and CSF-tau. Utilizing the results from independent case-control AD GWAS to construct polygenic risk scores (PRS) revealed that AD risk variants only explain a small fraction of CSF biomarker variability. In conclusion, our study represents a detailed first account of GWAS analyses on CSF-A{beta} and -tau related traits in the EMIF-AD MBD dataset. In subsequent work, we will utilize the genomics data generated here in GWAS of other AD-relevant clinical outcomes ascertained in this unique dataset.

genomics↗